Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03496519
Title Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid Tumors
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Colorado, Denver
Indications
Therapies
Age Groups: senior | adult
Covered Countries


No variant requirements are available.